J&J to ask FDA to approve its COVID-19 booster shot
Oct 04, 2021
Company has said that a second dose, given two months after the first, increases the vaccine’s effectiveness
CDC safety panel: J&J vaccine benefits outweigh rare neuro risks seen in older adults
By
Alicia Lasek
Jul 26, 2021
The benefits of the shot — including reduced hospitalization, intensive care unit admission and death — outweigh the risk of contracting Guillain-Barre syndrome, the Advisory Committee on Immunization...
COVID-19 vaccinations are essentially at a standstill in U.S. nursing homes and assisted living communities due to federal officials’ call today for a pause on the use of the Johnson & Johnson vaccine.
Second J&J shot ‘significantly’ increases COVID-19 antibodies; firm heads toward approval process
By
Danielle Brown
Aug 26, 2021
A Johnson & Johnson COVID-19 booster could be made available to long-term care residents and healthcare providers, as well as the rest of the American public, after the company unveiled promising results...
LTC vaccinators opt to briefly halt J&J shots while awaiting FDA guidance
By
Alicia Lasek
Apr 14, 2021
Long-term care pharmacies and clinicians have temporarily paused their use of Johnson & Johnson’s COVID vaccine following recommendations from health officials. Guidance is needed quickly in order to...